| Literature DB >> 9345404 |
O Fernández1, A Antiquëdad, T Arbizu, A Capdevíla, P de Castro, J C Correa de Sa, J A García-Merino, G Izquierdo, A Magalhaes, X Montalbán.
Abstract
Preliminary results of a multicenter, randomized study on the effect of natural interferon beta (n-INFN-beta) in relapsing-remitting MS are reported. Sixty patients received either no treatment or n-IFN-beta (9 MIU three times a week, subcutaneously). After 6 months, the n-IFN-beta-treated group showed a 58% median reduction in the number of active lesions detected on monthly magnetic resonance imaging scans as well as a 38% reduction in the exacerbation rate as compared with the control group. Side-effects were mild and self-limiting. The study continues according to the protocol.Entities:
Mesh：
Substances：
Year: 1995 PMID： 9345404
Source DB: PubMed Journal: Mult Scler ISSN： 1352-4585 Impact factor: 6.312